What is the current share price of Natco Pharma Limited (NATCOPHARM)?

As of the latest market update, Natco Pharma Limited (NATCOPHARM) is trading at ₹984.1. The stock has moved 2.34% up in the recent session.

What is the technical sentiment for NATCOPHARM stock?

Based on our proprietary technical analysis, the current signal for NATCOPHARM is "STRONG_BUY". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Natco Pharma Limited?

Natco Pharma Limited has seen a 52-week high of ₹1,226.8 and a 52-week low of ₹789. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Natco Pharma Limited belong to?

Natco Pharma Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of NATCOPHARM?

Natco Pharma Limited (NATCOPHARM) has a market capitalization of approximately ₹17.63K Cr. This classifies it as a small cap stock in the Indian market.

NATCOPHARM

NSE

Natco Pharma Limited (SMALL CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹984.10

22.50 (2.34%)

High VOLATILITY

As on 10 Jul 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹17.63K Cr

SMALL CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

12.8

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹789+24.7%

52W High₹1,226.8-19.8%

Current Price

₹984.10

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹787.28

Upper Circuit₹1,180.92

Reference Price

₹984.10

Investment Checklist

Triple Bottom on 1W (BREAKOUT CONFIRMED) — target ₹1131.8

Double Bottom on 1W (BREAKOUT CONFIRMED) — target ₹1128.75

Trend: Price above all key MAs — strong uptrend

Composite score 56.99 (STRONG_BUY) with 90.2% confidence

EMA(50) Crossover: Price crossed above EMA(50): Fresh bullish momentum signal.

Technical Analysis

Analysis from 2026-07-11

Confidence

90%

Trend

BULLISH

Price above all key MAs — strong uptrend

EMA20

941.44

EMA50

972.47

EMA200

953.84

Price Action

MIXED

NEUTRAL

Higher Highs5

Higher Lows6

Lower Highs4

Lower Lows3

Support & Resistance Levels

Resistance (Above)

₹1042.25

₹1056.00

₹1129.95

₹1202.00

₹1226.80

Support (Below)

₹954.12

₹928.20

₹896.95

₹883.23

₹866.37

Volume Analysis

TrendSTABLE

Change+2.00%

Unusual VolumeNo

Stop Loss Levels

Fixed Risk

1% Risk₹974.26

3% Risk₹954.58

5% Risk₹934.89

7% Risk (Custom)

₹915.21

Technical Levels

1x ATR (Volatility)₹950.11

2x ATR (Swing)₹916.12

3x ATR (Trend)₹882.13

Immediate Support₹954.12

Moving Averages

EMA 9 (Short-term)₹951.86

EMA 20 (Medium-term)₹941.44

EMA 50 (Trend)₹972.47

EMA 200 (Long-term)₹953.84

Financials

Financial Analysis

Metric	Mar '25	Jun '25	Sep '25	Dec '25
Revenue	₹1,203.1 Cr	₹1,328.9 Cr	₹1,363 Cr	₹647.3 Cr
Net Profit	₹406.6 Cr	₹480.7 Cr	₹518.4 Cr	₹151.5 Cr
EPS	—	₹26.84	₹28.94	₹8.46
Operating Profit	₹607.5 Cr	₹632.7 Cr	₹679.2 Cr	₹216.8 Cr

ROE

24.79%

ROCE

29.27%

Debt/Equity

0.04

Current Ratio

5.59

OPM

33.49%

NPM

23.40%

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change	P/E Ratio	Market Cap
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,935.50	-0.17%	40.2	₹4.64L Cr large Cap
DIVISLAB	Divi's Laboratories Limited	₹6,836.00	+0.34%	70.7	₹1.81L Cr large Cap
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,901.50	+0.07%	77.6	₹1.66L Cr large Cap
CIPLA	Cipla Limited	₹1,439.40	-0.13%	30.1	₹1.16L Cr large Cap
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,150.80	-0.71%	22.8	₹1.16L Cr large Cap
LUPIN	Lupin Limited	₹2,496.30	-0.28%	21.3	₹1.14L Cr mid Cap
MANKIND	Mankind Pharma Limited	₹2,525.10	-0.27%	54.1	₹1.04L Cr mid Cap
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,244.30	-1.99%	25.1	₹1.04L Cr large Cap
AUROPHARMA	Aurobindo Pharma Limited	₹1,564.70	-1.43%	25.7	₹90.88K Cr mid Cap
LAURUSLABS	Laurus Labs Limited	₹1,537.80	+2.02%	93.4	₹83.02K Cr mid Cap
NATCOPHARM	Natco Pharma Limited	₹984.10	+2.34%	12.9	₹17.63K Cr small Cap

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
18 Feb 2026	Interim Dividend - Rs 1.50 Per Share	INTERIM_DIVIDEND
20 Nov 2025	Interim Dividend - Rs 1.50 Per Share	INTERIM_DIVIDEND
19 Aug 2025	Interim Dividend - Rs 2 Per Share	INTERIM_DIVIDEND
18 Feb 2025	Interim Dividend - Rs 1.50 Per Share	INTERIM_DIVIDEND
27 Nov 2024	Interim Dividend - Rs 1.50 Per Share	INTERIM_DIVIDEND

Announcements

Latest updates

View All

Date	Description	Link
09 Jul 2026	Certificate under SEBI (Depositories and Participants) Regulations, 2018
08 Jul 2026	Outcome of Board Meeting
06 Jul 2026	Change in Management
30 Jun 2026	Retirement
30 Jun 2026	Trading Window

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
29 May 2026	Financial Results
29 May 2026	Board Meeting Intimation	XBRL
24 Mar 2026	Board Meeting Intimation	XBRL
24 Mar 2026	Other business matters
12 Feb 2026	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for NATCOPHARM

View All

positive

Business Standard - Markets 2d ago

Natco Pharma gains nearly 3% on ₹2,500 crore South Africa investment plan

Natco Pharma has announced investments of nearly ₹2,500 crore in South Africa, including infusing ₹1,400 crore in its arm in the country with an aim to enter new geographies.

BFINVESTNATCOPHARMFinancial ServicesHealthcare

Read full story

Stocks in news: TCS, Nalco, Maruti Suzuki, Natco Pharma, HFCL

positive

ET Markets - Stocks 2d ago

Stocks in news: TCS, Nalco, Maruti Suzuki, Natco Pharma, HFCL

Indian markets saw a significant decline on Wednesday, influenced by global factors. TCS anticipates modest profit growth amid client spending caution and wage pressures. Nalco and NLC India will form a joint venture for a power plant. HFCL plans substantial investment to boost optical fibre cable production capacity. Natco Pharma announced significant investments and stake increases in South Africa.

BFINVESTGLOBALGVPILHFCLMARUTINATCOPHARMNLCINDIASOUTHBANKTCSAutomobile and Auto ComponentsCapital Goods

Read full story

Natco Pharma to invest Rs 2,500 crore in South Africa expansion

positive

ET Markets - Industry 3d ago

Natco Pharma to invest Rs 2,500 crore in South Africa expansion

Natco Pharma will invest nearly Rs 2,500 crore in South Africa. This includes Rs 1,400 crore for its local subsidiary. The company will also increase its stake in Adcock Ingram. This acquisition is valued at Rs 1,069 crore. The transaction aims to expand Natco's geographic footprint.

NATCOPHARMHealthcare

Read full story

NATCOPHARM

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for NATCOPHARM

Natco Pharma gains nearly 3% on ₹2,500 crore South Africa investment plan

Stocks in news: TCS, Nalco, Maruti Suzuki, Natco Pharma, HFCL

Natco Pharma to invest Rs 2,500 crore in South Africa expansion

Frequently Asked Questions

What is the current share price of Natco Pharma Limited (NATCOPHARM)?

What is the technical sentiment for NATCOPHARM stock?

What is the 52-week high and low for Natco Pharma Limited?

Which sector does Natco Pharma Limited belong to?

What is the market capitalization of NATCOPHARM?